WANYI SCIENCE(SH:688600) Zheng Quan Ri Bao·2025-04-29 02:03Core Viewpoint - The company held its 22nd meeting of the fifth board of directors on April 28, 2025, where several important resolutions were passed regarding the 2024 annual report, financial results, and stock incentive plans [9][10][31]. Financial Data - The company reported a revenue of CNY 740,319,387.17 for 2024, a decrease of 5.92% compared to the previous year [31]. - The net profit attributable to shareholders was CNY 14,407,283.39, down 67.11% year-on-year [31]. - The net profit after deducting non-recurring gains and losses was CNY -1,974,198.82, a decline of 107.95% compared to the previous year [31]. Shareholder Information - The total number of shares eligible for dividend distribution is 125,322,411 after excluding 9,386,079 shares held in the company's repurchase account [39]. - The proposed cash dividend is CNY 1.00 per 10 shares, totaling CNY 12,532,241.10 (including tax) [39][40]. Stock Incentive Plan - The company decided to cancel 125,760 shares of restricted stock due to non-fulfillment of performance conditions and the departure of certain incentive targets [100][101]. - The performance conditions required a net profit growth rate of at least 107% or a revenue growth rate of at least 107% compared to 2020 [100]. Governance and Compliance - The board confirmed that the 2024 annual report and its summary complied with relevant laws and regulations, ensuring the accuracy and completeness of the information disclosed [10][31]. - The company has established a "Quality Improvement and Efficiency Enhancement" action plan for 2025 to enhance operational efficiency and shareholder returns [83]. Upcoming Events - The company will hold its 2024 annual general meeting on May 19, 2025, to discuss the annual report and other key resolutions [85].